- Home
- Taking on heart disease
Taking on heart disease
At Johnson & Johnson, we have an unrelenting vision to ease the tremendous global burden of cardiovascular disease. From anticoagulation, to advanced mapping and catheter ablation to treat atrial fibrillation, to cutting-edge technology that enables heart recovery through temporarily assisting the pumping function of the heart, to next generation investigational antithrombotics with the potential to help address unmet needs in acute coronary syndrome and stroke, our medical technologies and therapeutics are helping treat some of the most prevalent heart conditions, driving better outcomes and lasting impact for patients.
Innovating in Health&Care
5 things we now know about atrial fibrillation
More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. Learn the facts behind this heart condition, plus one patient’s diagnosis story.
Do you know what heart failure is? (Hint: It’s probably not what you think)
Learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
Key things we now know about peripheral artery disease
The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
What’s the difference between a heart attack and cardiac arrest?
Both are life-threatening heart-health emergencies, but they are two distinct conditions with different causes and treatment. Here’s what a cardiologist wants you to know.
Inside the science of strokes
Strokes are responsible for around 140,000 deaths a year in the United States alone. Learn how Johnson & Johnson is innovating to help change that stat.
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
More from Johnson & Johnson
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
The future of immunology
Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.
5 things we now know about colorectal cancer
Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.